nach oben

Current Oral Health Reports

Erschienen in:

11.08.2023

The Association Between Periodontal Disease and Non-Alcoholic Fatty Liver Disease is Linked to Metabolic Disorders

verfasst von: Yuto Kusu, Michiko Furuta, Toru Takeshita

Erschienen in: Current Oral Health Reports | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Non-alcoholic fatty liver disease (NAFLD) is recognized as the most common cause of chronic liver disease. NAFLD regularly coexists with metabolic disorders such as obesity and diabetes. Periodontal disease is associated with metabolic disorders. Both diseases have overlapping risk factors; hence, periodontal disease may be associated with NAFLD. This review discusses the reciprocal associations between periodontal disease, NAFLD, and metabolic disorders.

Recent Findings

Numerous cross-sectional studies have reported an association between periodontal disease and NAFLD. Limited prospective evidence suggests that periodontal disease is a predictor of NAFLD. Furthermore, periodontal disease is associated with the fibrotic progression of NAFLD. Several studies have indicated that metabolic disorders enhance the association between periodontal disease and NAFLD.

Summary

Periodontal disease could exacerbate NAFLD in coexisting metabolic disorders with a source of systemic inflammation and oxidative stress. Additional prospective studies on periodontal disease, NAFLD, and metabolic disorders are required to better understand the potential causative mechanisms.

Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol. 2010;53(2):372–84. https://doi.org/10.1016/j.jhep.2010.04.008.CrossRefPubMed

Le MH, Yeo YH, Li X, Li J, Zou B, Wu Y, et al. 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2022;20(12):2809-17.e28. https://doi.org/10.1016/j.cgh.2021.12.002.CrossRefPubMed

Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2010;28(1):155–61. https://doi.org/10.1159/000282080.CrossRefPubMed

Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005–23. https://doi.org/10.1002/hep.25762.CrossRefPubMed

Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10(11):686–90. https://doi.org/10.1038/nrgastro.2013.171.CrossRefPubMed

Allende DS, Gawrieh S, Cummings OW, Belt P, Wilson L, Van Natta M, et al. Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosis. Liver Int. 2021;41(5):996–1011. https://doi.org/10.1111/liv.14773.CrossRefPubMedPubMedCentral

Stasi C, Silvestri C, Voller F, Cipriani F. Epidemiology of Liver Cirrhosis. J Clin Exp Hepatol. 2015;5(3):272. https://doi.org/10.1016/j.jceh.2015.06.002.CrossRefPubMedPubMedCentral

Li B, Zhang C, Zhan YT. Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis. Can J Gastroenterol Hepatol. 2018;2018:2784537. https://doi.org/10.1155/2018/2784537.CrossRefPubMedPubMedCentral

Enomoto H, Ueno Y, Hiasa Y, Nishikawa H, Hige S, Takikawa Y, et al. Transition in the etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol. 2019;1–10. https://doi.org/10.1007/s00535-019-01645-y.

10.

Bertuccio P, Turati F, Carioli G, Rodriguez T, La Vecchia C, Malvezzi M, et al. Global trends and predictions in hepatocellular carcinoma mortality. J Hepatol. 2017;67(2):302–9. https://doi.org/10.1016/j.jhep.2017.03.011.CrossRefPubMed

11.

Alakhali MS, Al-Maweri SA, Al-Shamiri HM, Al-Haddad K, Halboub E. The potential association between periodontitis and non-alcoholic fatty liver disease: a systematic review. Clin Oral Investig. 2018;22(9):2965–74. https://doi.org/10.1007/s00784-018-2726-1.CrossRefPubMed

12.

Xu F, Tang J. Is There An Association Between Periodontitis And Non-Alcoholic Fatty Liver Disease? A Systematic Review and Meta-Analysis. Community Dent Health. 2023;40(1):47–52. https://doi.org/10.1922/CDH_00180Xu06.CrossRefPubMed

13.

Kobayashi T, Iwaki M, Nogami A, Honda Y, Ogawa Y, Imajo K, et al. Involvement of Periodontal Disease in the Pathogenesis and Exacerbation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: A Review. Nutrients. 2023;15(5). https://doi.org/10.3390/nu15051269

14.

Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366(9499):1809–20. https://doi.org/10.1016/s0140-6736(05)67728-8.CrossRefPubMed

15.

Levine RS. Obesity, diabetes and periodontitis–a triangular relationship? Br Dent J. 2013;215(1):35–9. https://doi.org/10.1038/sj.bdj.2013.627.CrossRefPubMed

16.

Brunt EM, Wong VW, Nobili V, Day CP, Sookoian S, Maher JJ, et al. Nonalcoholic fatty liver disease. Nat Rev Dis Primers. 2015;1:15080. https://doi.org/10.1038/nrdp.2015.80.CrossRefPubMed

17.

Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52(5):1836–46. https://doi.org/10.1002/hep.24001.CrossRefPubMed

18.

Shin HS. Association between periodontal status and non-alcoholic fatty liver disease in a Korean adult population: A nationwide cross-sectional study. J Periodontol. 2020;91(4):524–32. https://doi.org/10.1002/jper.19-0291.CrossRefPubMed

19.

Weintraub JA, Lopez Mitnik G, Dye BA. Oral Diseases Associated with Nonalcoholic Fatty Liver Disease in the United States. J Dent Res. 2019;98(11):1219–26. https://doi.org/10.1177/0022034519866442.CrossRefPubMedPubMedCentral

20.

Iwasaki T, Hirose A, Azuma T, Ohashi T, Watanabe K, Obora A, et al. Correlation between ultrasound-diagnosed non-alcoholic fatty liver and periodontal condition in a cross-sectional study in Japan. Sci Rep. 2018;8(1):7496. https://doi.org/10.1038/s41598-018-25857-z.CrossRefPubMedPubMedCentral

21.

Qiao F, Fu K, Zhang Q, Liu L, Meng G, Wu H, et al. The association between missing teeth and non-alcoholic fatty liver disease in adults. J Clin Periodontol. 2018;45(8):941–51. https://doi.org/10.1111/jcpe.12929.CrossRefPubMed

22.

Akinkugbe AA, Barritt AS, Cai J, Offenbacher S, Thyagarajan B, Khambaty T, et al. Periodontitis and prevalence of elevated aminotransferases in the Hispanic Community Health Study/Study of Latinos. J Periodontol. 2018;89(8):949–58. https://doi.org/10.1002/jper.17-0579.CrossRefPubMedPubMedCentral

23.

Akinkugbe AA, Avery CL, Barritt AS, Cole SR, Lerch M, Mayerle J, et al. Do Genetic Markers of Inflammation Modify the Relationship between Periodontitis and Nonalcoholic Fatty Liver Disease? Findings from the SHIP Study. J Dent Res. 2017;96(12):1392–9. https://doi.org/10.1177/0022034517720924.CrossRefPubMedPubMedCentral

24.

Sato S, Kamata Y, Kessoku T, Shimizu T, Kobayashi T, Kurihashi T, et al. A cross-sectional study assessing the relationship between non-alcoholic fatty liver disease and periodontal disease. Sci Rep. 2022;12(1):13621. https://doi.org/10.1038/s41598-022-17917-2.CrossRefPubMedPubMedCentral

25.

Nakahara T, Hyogo H, Ono A, Nagaoki Y, Kawaoka T, Miki D, et al. Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease. J Gastroenterol. 2018;53(2):269–80. https://doi.org/10.1007/s00535-017-1368-4.CrossRefPubMed

26.

Komazaki R, Katagiri S, Takahashi H, Maekawa S, Shiba T, Takeuchi Y, et al. Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism. Sci Rep. 2017;7(1):13950. https://doi.org/10.1038/s41598-017-14260-9.CrossRefPubMedPubMedCentral

27.

Alazawi W, Bernabe E, Tai D, Janicki T, Kemos P, Samsuddin S, et al. Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease. PLoS One. 2017;12(12):e0185902. https://doi.org/10.1371/journal.pone.0185902

28.

• Shin HS, Hong MH, Moon JY, Sim SJ. Periodontal disease could be a potential risk factor for non-alcoholic fatty liver disease: An 11-year retrospective follow-up study. Clin Oral Investig. 2022;26(8):5503–14. https://doi.org/10.1007/s00784-022-04518-6. This cohort study shows longitudinal association between periodontal disease and NAFLD in a large population study.

29.

•• Kuroe K, Furuta M, Takeuchi K, Takeshita T, Suma S, Shinagawa T, et al. Association between periodontitis and fibrotic progression of non-alcoholic fatty liver among Japanese adults. J Clin Periodontol. 2021;48(3):368–77. https://doi.org/10.1111/jcpe.13415. This cohort study provides important evidence for the association between periodontal disease, progression of NAFLD, and obesity.

30.

Helenius-Hietala J, Suominen AL, Ruokonen H, Knuuttila M, Puukka P, Jula A, et al. Periodontitis is associated with incident chronic liver disease-A population-based cohort study. Liver Int. 2019;39(3):583–91. https://doi.org/10.1111/liv.13985.CrossRefPubMed

31.

Akinkugbe AA, Slade GD, Barritt AS, Cole SR, Offenbacher S, Petersmann A, et al. Periodontitis and Non-alcoholic Fatty Liver Disease, a population-based cohort investigation in the Study of Health in Pomerania. J Clin Periodontol. 2017;44(11):1077–87. https://doi.org/10.1111/jcpe.12800.CrossRefPubMedPubMedCentral

32.

de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol. 2008;48(Suppl 1):S104–12. https://doi.org/10.1016/j.jhep.2008.01.009.CrossRefPubMed

33.

Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846–54. https://doi.org/10.1002/hep.21496.CrossRefPubMed

34.

Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33. https://doi.org/10.1186/1471-230x-6-33.CrossRefPubMedPubMedCentral

35.

Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15(1):30–44. https://doi.org/10.1038/nri3785.CrossRefPubMedPubMedCentral

36.

Martínez-García M, Hernández-Lemus E. Periodontal Inflammation and Systemic Diseases: An Overview. Front Physiol. 2021;12:709438. https://doi.org/10.3389/fphys.2021.709438

37.

Fentoğlu Ö, Köroğlu BK, Hiçyılmaz H, Sert T, Özdem M, Sütçü R, et al. Pro-inflammatory cytokine levels in association between periodontal disease and hyperlipidaemia. J Clin Periodontol. 2011;38(1):8–16. https://doi.org/10.1111/j.1600-051X.2010.01644.x.CrossRefPubMed

38.

Li M, Cai SY, Boyer JL. Mechanisms of bile acid mediated inflammation in the liver. Mol Aspects Med. 2017;56:45–53. https://doi.org/10.1016/j.mam.2017.06.001.CrossRefPubMedPubMedCentral

39.

Ritchie CS, Kinane DF. Nutrition, inflammation, and periodontal disease. Nutrition. 2003;19(5):475–6. https://doi.org/10.1016/s0899-9007(02)01043-2.CrossRefPubMed

40.

Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol. 2004;142(2):231–55. https://doi.org/10.1038/sj.bjp.0705776.CrossRefPubMedPubMedCentral

41.

Tomofuji T, Ekuni D, Irie K, Azuma T, Tamaki N, Maruyama T, et al. Relationships between periodontal inflammation, lipid peroxide and oxidative damage of multiple organs in rats. Biomed Res. 2011;32(5):343–9. https://doi.org/JST.JSTAGE/biomedres/32.343 [pii].

42.

Brandl K, Kumar V, Eckmann L. Gut-liver axis at the frontier of host-microbial interactions. Am J Physiol Gastrointest Liver Physiol. 2017;312(5):G413–9. https://doi.org/10.1152/ajpgi.00361.2016.CrossRefPubMedPubMedCentral

43.

Di Ciaula A, Baj J, Garruti G, Celano G, De Angelis M, Wang HH, et al. Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk. J Clin Med. 2020;9(8). https://doi.org/10.3390/jcm9082648

44.

Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, et al. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018;15(7):397–411. https://doi.org/10.1038/s41575-018-0011-z.CrossRefPubMedPubMedCentral

45.

Leung C, Rivera L, Furness JB, Angus PW. The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol. 2016;13(7):412–25. https://doi.org/10.1038/nrgastro.2016.85.CrossRefPubMed

46.

Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–14. https://doi.org/10.1038/nature11234.

47.

Humphrey SP, Williamson RT. A review of saliva: normal composition, flow, and function. J Prosthet Dent. 2001;85(2):162–9. https://doi.org/10.1067/mpr.2001.113778.CrossRefPubMed

48.

Giannella RA, Broitman SA, Zamcheck N. Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut. 1972;13(4):251–6. https://doi.org/10.1136/gut.13.4.251.CrossRefPubMedPubMedCentral

49.

Begley M, Gahan CG, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev. 2005;29(4):625–51. https://doi.org/10.1016/j.femsre.2004.09.003.CrossRefPubMed

50.

Kageyama S, Sakata S, Ma J, Asakawa M, Takeshita T, Furuta M, et al. High-Resolution Detection of Translocation of Oral Bacteria to the Gut. J Dent Res. 2023:220345231160747. https://doi.org/10.1177/00220345231160747

51.

Albuquerque-Souza E, Sahingur SE. Periodontitis, chronic liver diseases, and the emerging oral-gut-liver axis. Periodontol. 2022;89(1):125–41. https://doi.org/10.1111/prd.12427

52.

Li L, Liu DW, Yan HY, Wang ZY, Zhao SH, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016;17(6):510–9. https://doi.org/10.1111/obr.12407.CrossRefPubMed

53.

Samocha-Bonet D, Dixit VD, Kahn CR, Leibel RL, Lin X, Nieuwdorp M, et al. Metabolically healthy and unhealthy obese–the 2013 Stock Conference report. Obes Rev. 2014;15(9):697–708. https://doi.org/10.1111/obr.12199.CrossRefPubMedPubMedCentral

54.

du Plessis J, van Pelt J, Korf H, Mathieu C, van der Schueren B, Lannoo M, et al. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015;149(3):635-48.e14. https://doi.org/10.1053/j.gastro.2015.05.044.CrossRefPubMed

55.

Tilg H, Moschen AR, Szabo G. Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatology. 2016;64(3):955–65. https://doi.org/10.1002/hep.28456.CrossRefPubMed

56.

Furuta M, Yamashita Y. Epidemiological evidences for the association of obesity and metabolic disorders with oral diseases. Curr Oral Health Rep. 2017;4:51–8.CrossRef

57.

Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis. 2006;6(7):438–46. https://doi.org/10.1016/s1473-3099(06)70523-0.CrossRefPubMed

58.

Isakson P, Hammarstedt A, Gustafson B, Smith U. Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes. 2009;58(7):1550–7. https://doi.org/10.2337/db08-1770.CrossRefPubMedPubMedCentral

59.

Van Kaer L, Parekh VV, Wu L. Invariant natural killer T cells as sensors and managers of inflammation. Trends Immunol. 2013;34(2):50–8. https://doi.org/10.1016/j.it.2012.08.009.CrossRefPubMed

60.

Hegde V, Dhurandhar NV. Microbes and obesity–interrelationship between infection, adipose tissue and the immune system. Clin Microbiol Infect. 2013;19(4):314–20. https://doi.org/10.1111/1469-0691.12157.CrossRefPubMed

61.

Ahmad A, Furuta M, Shinagawa T, Takeuchi K, Takeshita T, Shimazaki Y, et al. Association of periodontal status with liver abnormalities and metabolic syndrome. J Oral Sci. 2015;57(4):335–43. https://doi.org/10.2334/josnusd.57.335.CrossRefPubMed

62.

Suresh S, Mahendra J, Sudhakar U, Pradeep AR, Singh G. Evaluation of plasma reactive oxygen metabolites levels in obese subjects with periodontal disease. Indian J Dent Res. 2016;27(2):155–9. https://doi.org/10.4103/0970-9290.183117.CrossRefPubMed

63.

Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202–9. https://doi.org/10.1016/j.jhep.2020.03.039.CrossRefPubMed

Titel: The Association Between Periodontal Disease and Non-Alcoholic Fatty Liver Disease is Linked to Metabolic Disorders
verfasst von: Yuto Kusu
Michiko Furuta
Toru Takeshita
Publikationsdatum: 11.08.2023
Verlag: Springer International Publishing
Erschienen in: Current Oral Health Reports / Ausgabe 4/2023
Elektronische ISSN: 2196-3002
DOI: https://doi.org/10.1007/s40496-023-00342-3

Insulin Resistance Is an Alternative, Novel Risk Factor for Diabetes-Associated Periodontitis

Sintering Strategies for Dental Zirconia Ceramics: Slow Versus Rapid?

Relationship of NLRP3 Inflammasome with Oral Health

Highlights in Contemporary Smart Dental Materials: a Review

Effectiveness of SAMITAL® for Management of Chemo/Radiotherapy-Induced Oral Mucositis in Patients with Cancer—a Systematic Review

The Impact of the COVID-19 Pandemic on Oral and Oropharyngeal Cancer

Open Access

Neu im Fachgebiet Zahnmedizin

Das alles ändert sich für Arztpraxen in 2025

31.12.2024
EBM
Nachrichten

Ab Januar greifen jede Menge Neuerungen – ob im EBM, Arbeits- und Steuerrecht oder bei der digitalen Vernetzung. Darunter einige Verbesserungen, aber teils auch Mehraufwand. „Same procedure as every year?“ – Ein Überblick.

Wenn Praxen Termine absagen müssen: So geht’s ohne Ärger und Stress

22.12.2024
Praxis und Beruf
Nachrichten

Bundesweit sind viele Praxen von Krankheitsfällen in den eigenen Reihen betroffen. Die Praxis-EDV und strukturierte Abläufe können notwendige Terminabsagen erleichtern.

Wie gefährlich sind suspekte Veränderungen in der Mundhöhle?

17.12.2024
Mundhöhlenkarzinom
Nachrichten

Wie hoch ist das Risiko, dass sich aus einer bereits verdächtigen Veränderung der Mundschleimhaut ein Karzinom entwickelt? Ein US-Team hat dazu das Patientenregister der Universität San Francisco ausgewertet.

Das deutsche Gesundheitssystem kränkelt und hat Fieber

22.11.2024
Gesundheitspolitik
Nachrichten

OECD und Europäische Kommission haben zusammen einen Bericht zum Zustand der europäischen Gesundheitssysteme herausgegeben. Diagnose für Deutschland: Wäre das Land ein menschliches Wesen, würde man es wohl krankschreiben.

Update Zahnmedizin

Bestellen Sie unseren kostenlosen Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

The Association Between Periodontal Disease and Non-Alcoholic Fatty Liver Disease is Linked to Metabolic Disorders

Abstract

Purpose of Review

Recent Findings

Summary

Weitere Artikel der Ausgabe 4/2023

Insulin Resistance Is an Alternative, Novel Risk Factor for Diabetes-Associated Periodontitis

Sintering Strategies for Dental Zirconia Ceramics: Slow Versus Rapid?

Relationship of NLRP3 Inflammasome with Oral Health

Highlights in Contemporary Smart Dental Materials: a Review

Effectiveness of SAMITAL® for Management of Chemo/Radiotherapy-Induced Oral Mucositis in Patients with Cancer—a Systematic Review

The Impact of the COVID-19 Pandemic on Oral and Oropharyngeal Cancer

Neu im Fachgebiet Zahnmedizin

Das alles ändert sich für Arztpraxen in 2025

Wenn Praxen Termine absagen müssen: So geht’s ohne Ärger und Stress

Wie gefährlich sind suspekte Veränderungen in der Mundhöhle?

Das deutsche Gesundheitssystem kränkelt und hat Fieber

Update Zahnmedizin

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten